Mass spectrometry imaging of phosphatidylcholine metabolism in lungs administered with therapeutic surfactants and isotopic tracers

Autor: Emily Hall, Shane R. Ellis, Jens Koed Madsen, Ron M. A. Heeren, Madhuriben H. Panchal, Howard Clark, Anthony D. Postle, Grielof Koster, Bryn Flinders
Přispěvatelé: Imaging Mass Spectrometry (IMS), RS: M4I - Imaging Mass Spectrometry (IMS)
Jazyk: angličtina
Rok vydání: 2021
Předmět:
0301 basic medicine
ELECTROSPRAY-IONIZATION
CLEARANCE
MSI
Mass spectrometry imaging

Endogeny
030204 cardiovascular system & hematology
Tandem mass spectrometry
Biochemistry
chemistry.chemical_compound
0302 clinical medicine
Endocrinology
Pulmonary surfactant
isotope labeling
ALVEOLAR MACROPHAGES
PLA1
Phospholipase A1

remodeling
PROTEIN-A
ATII
Alveolar epithelial type II

EtOH
Ethanol

DPPC
Dipalmitoyl phosphatidylcholine

TURNOVER
ARACHIDONIC-ACID METABOLISM
Research Article
PC
Phosphatidylcholine

TISSUES
Resolution (mass spectrometry)
QD415-436
PLA2
Phospholipase A2

Mass spectrometry imaging
lipids
03 medical and health sciences
Surface-Active Agents
MS/MS
Tandem mass spectrometry

Phosphatidylcholine
Labelling
BALF
Bronchoalveolar lavage fluid

KINETICS
matrix-assisted laser desorption/ionization
Lipid metabolism
Cell Biology
Metabolism
CHCL3
Chloroform

MeOH
Methanol

Matrix-assisted laser desorption/ionization
030104 developmental biology
chemistry
PHOSPHOLIPID-COMPOSITION
SIMS
Secondary ion mass spectrometry
Zdroj: Journal of Lipid Research, 62:100023. American Society for Biochemistry and Molecular Biology, Inc.
Journal of Lipid Research
Journal of Lipid Research, Vol 62, Iss, Pp 100023-(2021)
ISSN: 0022-2275
Popis: Mass spectrometry imaging (MSI) visualises molecular distributions throughout tissues but is blind to dynamic metabolic processes. Here, MSI with high mass resolution together with multiple stable isotope labelling provided spatial analyses of phosphatidylcholine (PC) metabolism in mouse lungs. Dysregulated surfactant metabolism is central to many respiratory diseases. Metabolism and turnover of therapeutic pulmonary surfactants were imaged from distributions of intact and metabolic products of an added tracer, universally13C-labelled dipalmitoyl PC (U[13C]DPPC). The parenchymal distributions of newly synthesised PC species were also imaged from incorporations ofmethyl-D9-choline. This dual labelling strategy demonstrated both lack of inhibition of endogenous PC synthesis by exogenous surfactant and location of acyl chain remodelling processes acting on the U[13C]DPPC-labelled surfactant, leading to formation of polyunsaturated PC lipids. This ability to visualise discrete metabolic events will greatly enhance our understanding of lipid metabolism in diverse tissues, and has potential application to both clinical and experimental studies.
Databáze: OpenAIRE